Tags |
|
|
Links |
|
|
Just Other Articles - Since You Asked
A long time ago, I bought a piece of mountain land for
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
future use. I intended to build my getaway cabin on i
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
t. The salesman was sure to tell me how good an invest
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ment it was, because land in the area was increasing i
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
n value. That was the justification I needed to buy wh
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
at I already wanted. But what he also did is the basis
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
for this piece.
He suggested that I buy two, "since
He suggested that I buy two, "since
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
it was such a good investment." I did.
Most of us hav
Most of us hav
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
e pulled into a fast food outlet to buy a sandwich, an
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
d invariably been asked if we would like something to
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
drink with it. This is done because it works.
Further
Further
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
more, side orders and drinks are the items that genera
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
te a majority of the profits, especially when one of u
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
s buys a $.99 sandwich.
Actually, the fast food worke
Actually, the fast food worke
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
r should not ask us if we want a drink, but rather wha
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
t we would like to drink.
The first question allows f
The first question allows f
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
or a negative response; the second assumes that we wan
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
t a drink and asks, "which kind?"
Realize that the ov
Realize that the ov
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
erhead costs come out of the primary purchase. The "ad
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
d-on" sales are all "net." "Ask and ye shall receive."
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justotherarticles.org.ua/article/28547/justotherarticles-Since-You-Asked.html">Since You Asked</a>
BB link (for phorums):
[url=http://www.justotherarticles.org.ua/article/28547/justotherarticles-Since-You-Asked.html]Since You Asked[/url]
Related Articles:
Make Life's Twists and Turns Interesting with Swivel Bar Stools
CPA, What Are Your Clients Saying About You?
Bookmark it:
|